GSK's asthma drug shows promise in reducing severe attacks
(Reuters) - GSK's asthma drug met its primary goal of reducing asthma attacks over a 52-week period in a late-stage trial, th...
10h ago
AstraZeneca aims to deliver $80 billion in total revenue by 2030
(Reuters) -AstraZeneca said on Tuesday it expects to deliver $80 billion in total revenue by 2030, boosted by the expected la...
10h ago
GSK faces whistleblower lawsuit over Zantac cancer risk
By Jonathan Stempel (Reuters) - GSK has been sued by an independent Connecticut laboratory that accused the drugmaker of defr...
20h ago
UnitedHealth's unit announces new drug pricing model
(Reuters) - UnitedHealth's unit OptumRx will begin offering a new pricing model from next year to help manage insurers' costs...
23h ago
US FDA approves Biocon unit's biosimilar to blockbuster eye drug Eylea
(Reuters) - The U.S. Food and Drug Administration on Monday approved Biocon unit's biosimilar to Regeneron Pharmaceuticals' b...
May 20, 2024
US FDA clears Neuralink's brain chip implant in second patient, WSJ reports
(Reuters) -The U.S. Food and Drug Administration has allowed billionaire Elon Musk's Neuralink to implant its brain chip in a...
May 20, 2024
UK's infected blood scandal could and should have been avoided, inquiry finds
By Paul Sandle LONDON (Reuters) - Britain's infected blood scandal that has killed 3,000 people and left thousands more suffe...
May 20, 2024
Shah Capital ends campaign against Novavax board after Sanofi deal
(Reuters) - Hedge fund Shah Capital said on Monday it would withdraw its campaign against the re-election of three directors ...
May 20, 2024
Kirin's electric spoon leaps from Ig Noble infamy to the dinner table
By Tom Bateman TOKYO (Reuters) - Japanese drinks giant Kirin Holdings will start selling an electrified spoon that researcher...
May 20, 2024
S.Africa's top poultry producer flags bird flu risk amid vaccine delays
(Reuters) - South Africa remains at risk of bird flu due to delays in the roll-out of a broad vaccination programme, the coun...
May 20, 2024